GFH375
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GFH375, covering 2025-11-17 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer [Phase 3]